Glaukos Corporation
General ticker "GKOS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $6.1B (TTM average)
Glaukos Corporation follows the US Stock Market performance with the rate: 11.0%.
Estimated limits based on current volatility of 1.5%: low 106.67$, high 109.82$
Factors to consider:
- Total employees count: 995 (+9.7%) as of 2024
- US accounted for 52.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Political instability, Strategic risks and growth management, Labor/talent shortage/retention, Integration challenges
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [87.56$, 177.29$]
- 2025-12-31 to 2026-12-31 estimated range: [66.14$, 140.05$]
Financial Metrics affecting the GKOS estimates:
- Negative: with PPE of -78.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.78 <= 0.33
- Positive: Shareholder equity ratio, % of 78.68 > 63.39
- Positive: Investing cash flow per share per price, % of 0.61 > -0.66
- Positive: Interest expense per share per price, % of 0.13 <= 0.79
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
Short-term GKOS quotes
Long-term GKOS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $282.86MM | $314.71MM | $383.48MM |
| Operating Expenses | $365.18MM | $443.41MM | $505.85MM |
| Operating Income | $-82.31MM | $-128.70MM | $-122.37MM |
| Non-Operating Income | $-16.12MM | $-5.03MM | $-23.23MM |
| Interest Expense | $13.72MM | $13.63MM | $10.04MM |
| R&D Expense | $123.27MM | $143.77MM | $150.65MM |
| Income(Loss) | $-98.43MM | $-133.73MM | $-145.60MM |
| Taxes | $0.77MM | $0.93MM | $0.77MM |
| Profit(Loss)* | $-99.19MM | $-134.66MM | $-146.37MM |
| Stockholders Equity | $530.00MM | $461.77MM | $766.93MM |
| Inventory | $37.84MM | $41.99MM | $57.68MM |
| Assets | $1,002.38MM | $940.41MM | $974.76MM |
| Operating Cash Flow | $-33.08MM | $-57.76MM | $-61.32MM |
| Capital expenditure | $30.27MM | $20.25MM | $6.30MM |
| Investing Cash Flow | $44.78MM | $14.10MM | $47.83MM |
| Financing Cash Flow | $6.25MM | $15.04MM | $91.54MM |
| Earnings Per Share** | $-2.09 | $-2.78 | $-2.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.